congrats to @alkuraya and team, who linked a novel facial dysmorphism to #TMEM94. https://t.co/yuatBNSDLc Noteworthy: affected individuals of all 6 families could also have been matched by #GestaltMatcher
#GestaltMatcher is now in review. Plz contact @thsieh_tw if you need technical support with dysmorphic similarity scores for your own papers. https://t.co/DIf4urwjj4
It is worth clicking through the videos - very interesting approaches! We are delighted to present our project as well 🧒2⃣🧬 #futuremed20#berlinscienceweek
Not enough time to read? Dr. Martin Atta Mensah explains the main points of the paper in just three minutes - if you like it, give us a five-star rating! https://t.co/E5qp416JBK #MachineLearning#FutureMedicine@ScienceMatch
Looking for some useful tips on how to interpret #Face2Gene's suggestions? Check out our new paper systematically evaluating #DeepGestalt's performance!
https://t.co/KU7dtyqoHV
New in JMIR: Efficiency of Computer-Aided Facial Phenotyping (DeepGestalt) in Individuals With and Without a Genetic Syndrome: Diagnostic Accuracy #Study https://t.co/r34mWxrCjj
We recommend a poster for the last minutes of the poster viewing session:
P16.28.A - Testing and improving DeepGestalt’s discriminatory power on photographs of individuals with and without a genetic syndrome
https://t.co/P8mZw57mny
#ESHG2020
I think this clip https://t.co/w3Nwh1Lmdy suggests that 0 cannot be the right answer. Otherwise no steady state could be reached, as affected removing from the gene pool is the only option to counteract de novo mutations
Everyone who liked the #montyhallproblem#ziegenproblem will love this one from genetics: In a population that is in a mutational steady state, how much higher is the #MutationLoad of an individual that is affected by a recessive disease compared to the average?
Can you beat the machine? Fascinating study that used ML to find M/F differences in the retina that ophthalmologists never noticed
https://t.co/lDdxNsEyCv
@KrawitzPeter#gestaltmatcher will soon be a service at #face2gene that will also be accessible via Genetalk. If you would like to learn more about how to include your patients let us know.